Barrett Asset Management’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-202
Closed -$43K 354
2021
Q4
$43K Buy
202
+12
+6% +$2.66K ﹤0.01% 409
2021
Q3
$42K Sell
190
-325
-63% -$73.9K ﹤0.01% 334
2021
Q2
$111K Hold
515
0.01% 239
2021
Q1
$104K Buy
515
+195
+61% +$36.6K 0.01% 235
2020
Q4
$60K Hold
320
﹤0.01% 254
2020
Q3
$54K Hold
320
﹤0.01% 246
2020
Q2
$54K Hold
320
﹤0.01% 245
2020
Q1
$58K Sell
320
-642
-67% -$132K ﹤0.01% 207
2019
Q4
$190K Buy
962
+378
+65% +$75.8K 0.01% 157
2019
Q3
$122K Buy
+584
New +$120K 0.01% 176
2016
Q2
Sell
-8,225
Closed -$640K 365
2016
Q1
$640K Hold
8,225
0.06% 109
2015
Q4
$715K Sell
8,225
-200
-2% -$16.1K 0.06% 105
2015
Q3
$616K Hold
8,425
0.06% 107
2015
Q2
$648K Buy
8,425
+6,625
+368% +$526K 0.05% 111
2015
Q1
$142K Sell
1,800
-4,000
-69% -$292K 0.01% 155
2014
Q4
$417K Hold
5,800
0.03% 132
2014
Q3
$385K Buy
5,800
+300
+5% +$21.2K 0.03% 133
2014
Q2
$417K Buy
5,500
+700
+15% +$52.2K 0.03% 131
2014
Q1
$351K Buy
4,800
+2,625
+121% +$188K 0.03% 131
2013
Q4
$152K Buy
+2,175
New +$138K 0.01% 163

Other funds holding LHX

Barrett Asset Management's LHX Position: Q1 2022 in Review

Barrett Asset Management sold out of L3Harris (LHX) in Q1 2022, closing a stake of 202 shares — an estimated $43K sold.

Barrett Asset Management first reported a position in LHX in Q4 2013 and held it in 20 quarters. The position peaked at $715K in Q4 2015. 1,236 funds tracked by Wall St. Rank hold LHX as of Q1 2022.

  • Barrett Asset Management reported no remaining L3Harris position as of Q1 2022 after selling out during the quarter.
  • Barrett Asset Management sold 202 L3Harris shares in Q1 2022, an estimated $43K.
  • Barrett Asset Management first reported a position in L3Harris in Q4 2013 and held it in 20 quarters.
  • Barrett Asset Management's L3Harris position peaked at $715K in Q4 2015.
  • 1,236 funds tracked by Wall St. Rank held L3Harris as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.